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Lead (Pb2+) poisoning causes hypertension, but little is known regarding its acute effects on cardiac contractility. To evaluate
these effects, force was measured in right ventricular strips that were contracting isometrically in 45 male Wistar rats (250-300
g) before and after the addition of increasing concentrations of lead acetate (3, 7, 10, 30, 70, 100, and 300 µM) to the bath.
Changes in rate of stimulation (0.1-1.5 Hz), relative potentiation after pauses of 15, 30, and 60 s, effect of Ca2+ concentration
(0.62, 1.25, and 2.5 mM), and the effect of isoproterenol (20 ng/mL) were determined before and after the addition of 100 µM Pb2+.
Effects on contractile proteins were evaluated after caffeine treatment using tetanic stimulation (10 Hz) and measuring the
activity of the myosin ATPase. Pb2+ produced concentration-dependent force reduction, significant at concentrations greater
than 30 µM. The force developed in response to increasing rates of stimulation became smaller at 0.5 and 0.8 Hz. Relative
potentiation increased after 100 µM Pb2+ treatment. Extracellular Ca2+ increment and isoproterenol administration increased
force development but after 100 µM Pb2+ treatment the force was significantly reduced suggesting an effect of the metal on the
sarcolemmal Ca2+ influx. Concentration of 100 µM Pb2+ also reduced the peak and plateau force of tetanic contractions and
reduced the activity of the myosin ATPase. Results showed that acute Pb2+ administration, although not affecting the
sarcoplasmic reticulum activity, produces a concentration-dependent negative inotropic effect and reduces myosin ATPase
activity. Results suggest that acute lead administration reduced myocardial contractility by reducing sarcolemmal calcium influx
and the myosin ATPase activity. These results also suggest that lead exposure is hazardous and has toxicological conse-
quences affecting cardiac muscle.
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Introduction
Lead is an environmental contaminant that damages
the human organism harming neural, renal and cardiovas-
cular systems, among others (1-4). Harmful effects de-
pend on plasma levels and on the duration of exposure.
Individuals with blood lead levels up to 29 µg/dL (1 to 1.4
µmol/L), currently considered to be an unsafe level, had
46% increased all-cause mortality, 39% increased circula-
tory mortality and 68% increased cancer mortality (5).
Previous research reported that exposure to low levels of
lead causes hypertension in animals and humans (6,7).
Analyzing data from the Third National Health and Nutri-
tion Examination Survey (NHANES, 1988-1994), a posi-
tive correlation was reported between plasma lead con-
centration and arterial pressure in black men and women
(8).
The etiology of lead-induced hypertension is reported
to be caused by the inhibition of Na,K-ATPase (9) and from
the reduced bioavailability of nitric oxide plus an increased
790
Braz J Med Biol Res 41(9) 2008
D.V. Vassallo et al.
www.bjournal.com.br
endothelial release of endothelin (10,11). The participation
of free radicals reducing nitric oxide bioavailability (12) and
depletion of antioxidant reserves (4) or its upregulation
(13) has been reported. Lead-induced hypertension also
involves the participation of peripheral or central nervous
system mechanisms, such as the increase of sympathetic
nerve activity, reduction of the baroreflex sensitivity and
reduction of parasympathetic tone (14,15).
Although lead-induced hypertension is well described,
few reports evaluated the effect of lead on the cardiac
muscle. Carmignani et al. (11,15) reported increased myo-
cardial inotropism and increased activity of the angio-
tensin-converting enzyme in rats exposed to 60 ppm lead
acetate for 10 months. On the other hand, Williams et al.
(16) reported negative inotropic effects on perfused hearts
caused by acute lead administration. Prentice and Kopp
(17) reported that lead significantly attenuated positive
inotropic response to increasing calcium concentrations in
perfused hearts. Bernal et al. (18) reported a calcium
channel blocker action of lead in rat myocytes and Xeno-
pus laevis oocytes.
Thus, the objective of this study was to determine the
acute action of increasing concentrations of lead acetate
on the contractile activity of the isolated rat ventricular
myocardium by measuring isometric twitch and tetanic
contractions of right ventricular strips, as well as the effect
on the myosin ATPase activity of rat hearts.
Material and Methods
Studies were performed on male Wistar rats (250-300
g). All experiments were conducted in compliance with the
guidelines for biomedical research as stated by the Brazil-
ian Societies of Experimental Biology. All rats had free
access to water and were fed rat chow ad libitum.
Right ventricular strips
Rats were anesthetized with sodium pentobarbital (65
mg/kg, ip), the thorax was opened and the hearts were
removed rapidly. The hearts were perfused through the
aortic stump with modified Tyrode solution (120 mM NaCl,
5.4 mM KCl, 1.2 mM MgCl2, 1.25 mM CaCl2, 2 mM HEPES
buffer, and 11 mM glucose, pH was adjusted to 7.4 with 4
M NaOH) to permit the proper selection and dissection of
the right ventricle strips. The preparations were immersed
in a 50-mL water-jack bath maintained at 26 ± 0.5°C and
gassed with 100% O2 to avoid hypoxia of the muscle core.
Preparations were attached to an isometric transducer
(Nihon-Kohden RMP-600, Japan). Field stimulation was
provided by isolated rectangular pulses (10-15 V, 5-10 ms
duration) applied through a pair of platinum electrodes
placed along the entire muscle extension. The standard
rate of stimulation was 0.5 Hz. Recordings started after 45-
60 min to let the beating preparation adapt to the new
environmental conditions. The force developed during con-
tractions was measured as mN of developed force divided
by g of muscle weight (mN/g). The correction by the strip
weight was used to normalize the data from different
preparations.
In the first protocol (strip weight = 24.8 ± 1.64 mg, N =
8), concentration-response curves to increasing concen-
trations of lead acetate (3, 7, 10, 30, 70, 100, and 300 µM)
were performed. Tests were performed at Lmax (optimum
length for contraction) and peak isometric force, time to
peak tension and relaxation time were measured.
The action of 100 µM lead acetate was evaluated by
the following protocols: post-rest potentiation; change of
rate of stimulation (0.1, 0.3, 0.5, 0.8, 1, and 1.5 Hz; strip
weight = 17.3 ± 1.64 mg; N = 8); change of external Ca2+
concentration (0.62, 1.25, and 2.5 mM; strip weight = 16 ±
1.36 mg; N = 8), and administration of isoproterenol (20 ng/
mL; strip weight = 14.8 ± 1.35 mg; N = 11). The post-rest
potentiation was obtained after pause intervals of 15, 30,
and 60 s and the results are presented as relative potentia-
tion (the amplitude of post-rest contractions divided by
steady-state contractions) to compare potentiations after
steady-state contractions of different amplitudes. Since
the rat myocardium saturates its positive inotropic re-
sponse at extracellular Ca2+ concentrations smaller than
that for other species (19), protocols using 20 ng/mL
isoproterenol were performed in the presence of low extra-
cellular Ca2+ concentrations (0.62 mM). For this group of
experiments, the concentration of 100 µM lead acetate
was used because it reduced isometric tension to approxi-
mately 30% of control tension (Figure 1).
In the last protocol (strip weight = 14.5 ± 1.06 mg; N =
10), tetanic tension was elicited, before and after 100 µM
lead acetate treatments by high frequency stimulation (5
Hz for 5-10 s). Tetanus was achieved after 5 mM caffeine
(B. Herzog, Brazil) pretreatment for 30 min and a time
interval of 15 min was used between tetanic stimulations.
Myosin ATPase activity
To determine if lead acetate is capable of affecting
myosin ATPase activity, the effects of this metal were
assayed as described previously (20,21). Briefly, myosin
was prepared from minced and homogenized right ven-
tricles (N = 7), extracted briefly with KCl phosphate buffer
(0.3 M KCl, 0.2 M phosphate buffer, pH 6.5) (22).
Myosin ATPase activity was assayed by measuring Pi
liberation from 1 mM ATP in the presence of 50 mM
HEPES, pH 7, 0.6 M KCl, 5 mM CaCl2, or 10 mM EGTA (N
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= 7) in the absence and in the presence of 100 µM lead
acetate.
Under this high ionic strength and no Mg2+ in the medi-
um, only myosin activity was measured and there is no
significant Ca2+-ATPase activity from sarcoplasmic reticu-
lum membranes, which requires high Mg2+ and low Ca2+
concentrations. Controls with addition of the enzyme prepa-
ration after addition of trichloroacetic acid were used to
correct for nonenzymatic hydrolysis of the substrate. All
measurements were performed in duplicate. The enzyme
activity was calculated as the difference between the ac-
tivities observed in the presence of Ca2+ and in the pres-
ence of 10 mM EGTA. Inorganic phosphate was deter-
mined by the method of Chan et al. (23). The specific
activity was reported as nmol Pi released per min per mg of
protein unless otherwise stated. Protein was measured by
the Coomassie blue method according to Bradford (24)
using bovine serum albumin as standard.
Drugs
The following drugs were used: sodium pentobarbital
(Cristalia Produtos Químicos Farmacêuticos Ltda., Brazil),
heparin (Roche Q.F.S.A., Brazil), anhydrous caffeine (B.
Herzog), bovine serum albumin, lead acetate, HEPES and
(-) isoproterenol hydrochloride (Sigma Chemical Co., USA).
All other reagents used were of analytical grade from
Sigma, E. Merck (Germany) or Reagen (Brazil).
Statistical analysis
The results are reported as means ± SEM with N
indicating the number of observations. Values were ana-
lyzed using the Student t-test and ANOVA (one- or two-
way). When ANOVA showed a significant difference, the
Tukey test was applied. P < 0.05 was considered to be
significant. Analysis of the data and plotting of the figures
were carried out using GraphPad Prism™ (version 2.0,
GraphPad Software, USA) and GB-STAT (version 4.0,
Dynamic Microsystem Inc., USA).
Results
Figure 1 shows the effects of increasing concentra-
tions of lead acetate on isometric force developed by right
ventricular strips. There was a concentration-dependent
force reduction that reached a 25% reduction with 100 µM
lead acetate compared to the control. However, there were
no concentration-dependent alterations of the time param-
eters time to peak tension and relaxation time of the
isometric contractions (data not shown).
Post-rest potentiation was used to determine if lead
could affect the function of the sarcoplasmic reticulum.
Post-rest potentiated contractions obtained after pauses
of 15, 30, and 60 s were recorded and analyzed as relative
potentiation before and after 100 µM lead acetate adminis-
tration (Figure 2). Lead reduced the magnitude of steady-
state contractions but induced a progressive increase in
relative potentiation (force under steady-state conditions:
control = 829 ± 65.5 mN/g; lead = 560 ± 43.3 mN/g; P <
0.05).
To determine if lead interferes with the muscle re-
sponse to positive inotropic intervention, changes of exter-
nal Ca2+ concentration and isoproterenol administration
Figure 1. Effects of increasing Pb2+ concentration on the isomet-
ric force of rat right ventricular strips. Data are reported as
means ± SEM for N = 8 measuremnts. *P < 0.01, Pb2+ vs control
(one-way ANOVA, repeated measures).
Figure 2. Effect of 100 µM Pb2+ on the relative potentiation (ratio
of post-rest contractions and steady-state contractions) of iso-
metric contractions of right ventricular strips obtained after
pauses of 15, 30, and 60 s. Control: filled columns; after Pb2+:
open columns. Rate of stimulation at 0.5 Hz. Data are reported
as means ± SEM for N = 8 measurements. *P < 0.05, Pb2+ vs
control (two-way ANOVA, repeated measures).
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cantly (P < 0.05) less compared with the control condition.
Using isoproterenol (20 ng/mL), the expected positive
inotropic effect was elicited (Figure 3B) and the force
increment produced by isoproterenol also occurred in the
presence of 100 µM lead acetate but with a reduced
magnitude.
Figure 4 shows the effects of 100 µM lead acetate on
changes in force by increasing the rate of stimulation. Lead
reduced isometric force development even when the rate
changed (0.1, 0.3, 0.5, 0.8, 1.0, and 1.5 Hz). In the control
group, force reduction was observed as the rate increased.
The same pattern was observed in the lead-treated group
but with a reduced magnitude.
We also determined if the depressant effect of lead
acetate was mediated solely via Ca2+ influx or whether it
could directly affect contractile proteins. To examine this
possibility, we tested the effects of 100 µM lead acetate on
tetanic contractions. Tetanic contractions developed a fast
upstroke (tetanic peak force) followed by a slow decay
(tetanic plateau force). Lead acetate depressed force de-
velopment of both the tetanic peak (control = 1348 ± 167 vs
lead = 859 ± 132 mN/g; P < 0.05) and the tetanic plateau
force (control = 902 ± 141 vs lead = 608 ± 76.7 mN/g; P <
0.05) developed by the ventricular strips. To show a direct
effect on the contractile proteins and because develop-
ment of tension also depends on myosin ATPase activity
(21), we investigated if lead acetate could reduce the
activity of this enzyme. Myosin Ca2+-ATPase activity was
assayed in the presence of 100 µM lead acetate showing a
reduction in percent (control = 100% and lead = 74.3 ±
8.61%; P < 0.05, t-test, repeated measures).
Figure 3. Effects of 100 µM Pb2+ on positive inotropic interventions produced by different (0.62, 1.25, and 2.5 mM) calcium
concentrations (A) and 20 ng/mL isoproterenol (ISO; B) on the isometric contractions of right ventricular strips. Rate of stimulation: 0.5
Hz. Data are reported as means ± SEM for N = 8 (calcium changes) or N = 11 (ISO measurements). A, *P < 0.05, Pb2+ vs control (two-
way ANOVA, repeated measures). B, *P < 0.05, ISO vs CT before and after Pb2+, and +P < 0.05, CT + Pb2+ vs CT and ISO + Pb2+ vs
ISO (one-way ANOVA, repeated measures).
Figure 4. Effects of 100 µM Pb2+ on the isometric contractions of
right ventricular strips at increasing rates of stimulation. Squares
= Pb2+; circles = control. Data are reported as means ± SEM for
N = 8 measurements. *P < 0.05, Pb2+ vs control (two-way
ANOVA, repeated measures).
were investigated. The dependence of force development
upon changes in external Ca2+ (0.62, 1.25, and 2.5 mM) in
the absence and presence of lead acetate (Figure 3A)
showed that, under control conditions and after lead ad-
ministration, Ca2+ increased the force in a concentration-
dependent way. However, in the presence of 100 µM lead
acetate, the increased force induced by Ca2+ was signifi-
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Discussion
The results presented here suggest that increasing
concentrations of lead acetate reduced the development
of isometric force and tetanic tension, and the activity of the
myosin ATPase without affecting sarcoplasmic reticulum
activity.
The toxic effects of lead in neural tissue and vessels
are well described. In the neural tissue, lead acts by
inhibiting Na,K-ATPase, increasing the production of free
radicals, which results in neural lesions (4,25). A hyperten-
sive effect was also reported and the action of lead is
related to impairment of endothelial function and also to
the production of free radicals (4,13,26). An increased
production of angiotensin II has also been reported as a
mechanism to induce hypertension (15).
Albeit the mechanisms of lead-induced hypertension
and its vascular effects are already known, cardiac actions
are poorly described. Few reports show that chronic lead
administration acts on the heart enhancing contractility
probably by increasing the production of angiotensin II
(15). Although chronic treatment increases contractility,
acute treatment blocks calcium channels in cardiac myo-
cytes and Xenopus laevis oocytes (18). These findings
suggest that lead affects the heart. We, thus, investigated
the actions of acute administration of increasing concen-
trations of lead on the isolated cardiac muscle.
Our results showed a concentration-dependent nega-
tive inotropic effect induced by the metal that became
significant at 30 µM. This force reduction was not followed
by significant changes in temporal parameters. The block-
ade of calcium channels could explain the force reduction.
However, the fact that lead binds to sulfhydryl (SH) groups
suggests that the metal could affect contractile proteins
(27,28). The activity of myosin, for example, is reduced by
Hg, which also binds to SH groups (21).
To investigate the effects of lead on contractile pro-
teins, tetanic contractions and the activity of myosin ATPase
were used. Tetanic stimulation obtained after inhibition of
sarcoplasmic reticulum activity with caffeine or ryanodine
has been used to produce maximal activation of the con-
tractile machinery in the intact myocardium (29,30). Caf-
feine acts by emptying the sarcoplasmic reticulum of its
calcium content and the sustained exposure to caffeine
prevents sarcoplasmic reticulum Ca2+ accumulation (31).
Since relaxation in the rat myocardium is a process mainly
dependent on sarcoplasmic reticulum Ca2+ reuptake, and
because rat myocardium has action potentials of short
duration and short refractory period, these features facili-
tate the development of tetanic contractions (32,33). Peak
force and plateau force developed by ventricular strips
treated with lead and under tetanic stimulations were de-
pressed. Once the sarcoplasmic reticulum activity is
blocked, tetanic contractions depend only on calcium in-
flux or on the activity of myosin ATPase. Thus, our results
suggest that lead reduced the sarcolemmal Ca2+ influx or
affected contractile proteins.
To investigate if tetanic tension reduction was also
dependent on the effects on the contractile proteins, the
effect of lead on myosin ATPase activity was investigated.
With 100 µM lead, the activity of myosin ATPase was
reduced. This effect is reasonable because lead binds to
SH groups (28) and the myosin molecule contains several
SH groups (27), and furthermore lead depletes glutathione
and protein-bound SH groups (25).
Time to peak tension and relaxation time depend on
how fast the activator calcium reaches the contractile
apparatus and the capacity of the myocyte to reduce
myoplasmic calcium. Mercury, for example, reduces time
to peak tension by increasing calcium release from the
sarcoplasmic reticulum upon activation (34,35). In the rat
myocardium, both kinetic parameters depend mainly on
the release of calcium upon activation of the sarcoplasmic
reticulum and the reuptake of calcium during relaxation
(36). The lack of effects on kinetic parameters supports the
finding obtained with the post-rest potentiation, which was
not affected by lead. When analyzing the relative potentia-
tion, it was observed that albeit reduction of force of the
steady-state contractions occurred, the relative potentia-
tion increased. This result suggests that the effect of lead
depends more on membrane Ca2+ influx through voltage-
sensitive channels than on Ca2+ released from the sarco-
plasmic reticulum. Similar behavior was reported using
verapamil and manganese, both Ca2+ channel blockers
(37), which reduce the transmembrane Ca2+ influx during
activation but do not affect sarcoplasmic reticulum activity.
Therefore, if Ca2+ entry is partially blocked, the relative
participation of the sarcoplasmic reticulum in tension de-
velopment increases and the first contraction after pause
is potentiated (37).
To determine if lead could change the capacity of
response to inotropic interventions, the increase of exter-
nal calcium concentrations, isoproterenol administration
and changes in the rate of stimulation were performed in
the absence and presence of the metal. When inotropic
interventions were induced in the presence of lead, force
was reduced but no changes in the pattern of the inotropic
interventions were observed. This force reduction was
maintained even when the muscle was under inotropic
interventions, such as increased extracellular Ca2+ con-
centration or changes in the rate of stimulation. This is an
interesting finding that suggests that the negative inotropic
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action of lead takes place without blunting the pattern of
the positive inotropic actions. The maintenance of the
pattern of those inotropic effects at lower force values and
the increase of relative potentiation described above rein-
force the suggestion that lead might act as a calcium
channel blocker, as previously reported (18).
The present findings reinforce the biological signifi-
cance of lead as an environmental contaminant that dam-
ages the human organism producing harmful effects to the
cardiovascular system. Although significant progress has
occurred regarding environmental contamination, there
are still serious problems produced by heavy metals. The
positive correlation between plasma lead concentration
and hypertension (6-8), one of the most prominent cardio-
vascular problems in many countries, and the increase of
all-cause mortality, including circulatory and cancer mor-
tality (5), reinforce the biological significance of lead as an
important hazard.
The main new findings presented here suggest that
acute lead administration although not affecting sarco-
plasmic reticulum activity, reduced myocardial contractility
by reducing sarcolemmal calcium influx and the myosin
ATPase activity. These findings also indicate that lead, in
addition of being an important hazard, is a risk factor
capable to affect cardiac function.
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